Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BFI Finance Indonesia Tbk (BFIN) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

BFI Finance Indonesia TbkTrade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

BFI Finance Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? BFI Finance Indonesia Tbk trades at Rp915 (market cap 13.76T, 2.26M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 31.1K 24h volume). The key difference: BFI Finance Indonesia Tbk is far larger — about 83.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and BFI Finance Indonesia Tbk is more actively traded (2.26M versus 31.1K). Which is the better fit depends on your goals.

BFINOBAT
Market Cap
13.76T164.65B
Volume
2.26M31.1K
Lot
22.59K311
Turnover
2.07B7.51M
Average Price
918.16241.62
Value
2.07B7.51M
Indicative Equilibrium Price
905238
Indicative Equilibrium Volume
121100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BFIN
View details
OBAT
View details

About BFI Finance Indonesia Tbk

PT BFI Finance Indonesia Tbk (the Company) formerly PT. Bunas Finance Indonesia Tbk (the Company) was established as PT Manufacturers Hanover Leasing Indonesia on April 7, 1982 based on Notarial deed No. 57 of Kartini Muljadi, S.H., Notary in Jakarta. Presently, the Company is engaged in leasing, consumer financing and factoring of accounts receivable. And changed to BFI Finance Indonesia on 2001

Read more on BFIN

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT